162 related articles for article (PubMed ID: 25990023)
1. Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral blood.
Beloki L; Ciaurriz M; Mansilla C; Zabalza A; Perez-Valderrama E; Samuel ER; Lowdell MW; Ramirez N; Olavarria E
J Transl Med; 2015 May; 13():165. PubMed ID: 25990023
[TBL] [Abstract][Full Text] [Related]
2. CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers.
Beloki L; Ciaurriz M; Mansilla C; Zabalza A; Perez-Valderrama E; Samuel ER; Lowdell MW; Ramirez N; Olavarria E
J Transl Med; 2014 Nov; 12():317. PubMed ID: 25406933
[TBL] [Abstract][Full Text] [Related]
3. Isolation of highly suppressive CD25+FoxP3+ T regulatory cells from G-CSF-mobilized donors with retention of cytotoxic anti-viral CTLs: application for multi-functional immunotherapy post stem cell transplantation.
Samuel ER; Beloki L; Newton K; Mackinnon S; Lowdell MW
PLoS One; 2014; 9(1):e85911. PubMed ID: 24465783
[TBL] [Abstract][Full Text] [Related]
4. Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors.
Beloki L; Ramírez N; Olavarría E; Samuel ER; Lowdell MW
Cytotherapy; 2014 Oct; 16(10):1390-408. PubMed ID: 24954783
[TBL] [Abstract][Full Text] [Related]
5. Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function.
Samuel ER; Newton K; Mackinnon S; Lowdell MW
Br J Haematol; 2013 Jan; 160(1):87-100. PubMed ID: 23043413
[TBL] [Abstract][Full Text] [Related]
6. Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease.
Odendahl M; Grigoleit GU; Bönig H; Neuenhahn M; Albrecht J; Anderl F; Germeroth L; Schmitz M; Bornhäuser M; Einsele H; Seifried E; Busch DH; Tonn T
Cytotherapy; 2014 Sep; 16(9):1245-56. PubMed ID: 25108651
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.
Clancy LE; Blyth E; Simms RM; Micklethwaite KP; Ma CK; Burgess JS; Antonenas V; Shaw PJ; Gottlieb DJ
Biol Blood Marrow Transplant; 2013 May; 19(5):725-34. PubMed ID: 23380344
[TBL] [Abstract][Full Text] [Related]
8. Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts.
Gary R; Aigner M; Moi S; Schaffer S; Gottmann A; Maas S; Zimmermann R; Zingsem J; Strobel J; Mackensen A; Mautner J; Moosmann A; Gerbitz A
J Transl Med; 2018 May; 16(1):124. PubMed ID: 29743075
[TBL] [Abstract][Full Text] [Related]
9. Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor.
Bunse CE; Borchers S; Varanasi PR; Tischer S; Figueiredo C; Immenschuh S; Kalinke U; Köhl U; Goudeva L; Maecker-Kolhoff B; Ganser A; Blasczyk R; Weissinger EM; Eiz-Vesper B
PLoS One; 2013; 8(12):e77925. PubMed ID: 24324576
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.
Bunse CE; Tischer S; Lahrberg J; Oelke M; Figueiredo C; Blasczyk R; Eiz-Vesper B
Clin Exp Immunol; 2016 Jul; 185(1):107-18. PubMed ID: 26990855
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
[TBL] [Abstract][Full Text] [Related]
12. Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation.
Otto M; Barfield RC; Iyengar R; Gatewood J; Müller I; Holladay MS; Houston J; Leung W; Handgretinger R
J Immunother; 2005; 28(1):73-8. PubMed ID: 15614047
[TBL] [Abstract][Full Text] [Related]
13. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
[TBL] [Abstract][Full Text] [Related]
14. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
[TBL] [Abstract][Full Text] [Related]
15. Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.
Hobeika A; Osada T; Serra D; Peplinski S; Hanson K; Tanaka Y; Niedzwiecki D; Chao N; Rizzieri D; Lyerly H; Clay T; Morse M
Cytotherapy; 2008; 10(3):289-302. PubMed ID: 18418774
[TBL] [Abstract][Full Text] [Related]
16. No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF.
Gazitt Y; Akay C; Thomas C
Stem Cells Dev; 2006 Apr; 15(2):269-77. PubMed ID: 16646673
[TBL] [Abstract][Full Text] [Related]
17. Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation.
Ogonek J; Verma K; Schultze-Florey C; Varanasi P; Luther S; Schweier P; Kühnau W; Göhring G; Dammann E; Stadler M; Ganser A; Koehl U; Koenecke C; Weissinger EM; Hambach L
J Immunol; 2017 Jul; 199(2):792-805. PubMed ID: 28630092
[TBL] [Abstract][Full Text] [Related]
18. Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes.
Watanabe N; Kamachi Y; Koyama N; Hama A; Liang J; Nakamura Y; Yamamoto T; Isomura M; Kudo K; Kuzushima K; Kojima S
Cytotherapy; 2004; 6(5):514-22. PubMed ID: 15512918
[TBL] [Abstract][Full Text] [Related]
19. Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation.
Kato R; Tamaki H; Ikegame K; Yoshihara S; Kaida K; Taniguchi K; Inoue T; Ishii S; Nakata J; Fujioka T; Eguchi R; Soma T; Okada M; Ogawa H
Ann Hematol; 2015 Oct; 94(10):1707-15. PubMed ID: 26193851
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
